Unimed provides health insurance services and operates a network of healthcare facilities in Brazil. Self-described as a cooperative, it focuses on comprehensive health care solutions for its members.

Unimed

汇医慧影 leverages medical imaging to provide intelligent solutions based on core technologies like computer vision and deep learning, encompassing AI-assisted diagnostic products and platforms, an artificial intelligence research platform, and a smart imaging data integration platform, aimed at helping global medical institutions and health management departments.

汇医慧影

Koios Medical provides AI-based clinical decision support for radiologists, focusing on breast and thyroid cancer diagnosis.

Koios Medical

Subtle Medical is a healthcare technology company that provides AI-powered image enhancement solutions. Its products, SubtlePET and SubtleMR, are FDA Cleared and CE Marked AI products that enhance images in PET and MR exams for faster and safer workflow. The company's SubtleGAD technology is also awarded by RSNA and has received a $1.6M NIH SBIR Grant to facilitate the adoption of AI for safer imaging exams. Subtle Medical aims to improve the quality, value, and accessibility of medical imaging by significantly reducing cost, imaging time, and radiation dose.

Metric
Company Name	Unimed	汇医慧影	Koios Medical	Subtle Medical
Symbol
MSH ID	BR:COOP:UNIMED	COM:HUIYIHUIYING	COM:KOIOSMEDICAL	COM:SUBTLEMEDICAL
Market	PRIVATE	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services	Radiology AI - Mammogram Analytics
Industry	Health Insurance	Medical Technology	Medical Technology	Healthcare & Life Sciences / Monitoring, Imaging & Diagnostics Tech
Country	BR	CN	US	US
Stage			Debt Financing
Employee Count				70
Website	unimed.coop.br	huiyihuiying.com	koiosmedical.com	subtlemedical.com
LinkedIn				subtlemedical
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic			594
Web Traffic Growth			0.25
Valuation
Raised Capital			170K

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

BR:COOP:UNIMED

Unimed

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue